Group Testing in the Presence of Error with Application to HIV/AIDS
应用于艾滋病毒/艾滋病时存在错误的群体测试
基本信息
- 批准号:7172594
- 负责人:
- 金额:$ 7.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcuteAlgorithmsAnalytical ChemistryAreaBackBiologicalBlood BanksCharacteristicsClassificationCommunicable DiseasesDetectionDiseaseDrug IndustryEatingEntomologyGeneticGrantHIVHIV InfectionsHealthHuman immunodeficiency virus testIndividualIndustryInformation TheoryInternationalLiteratureMethodologyMethodsMilitary PersonnelModelingMotivationMutationNorth CarolinaNumbersPharmacologic SubstancePopulationPredictive ValuePrevalencePreventionProceduresProtocols documentationRare DiseasesRateRecording of previous eventsResearchResearch PersonnelScreening procedureSensitivity and SpecificitySpecimenSyphilisSystemTechniquesTestingUnited StatesUniversitiesWorkbasecomputer sciencecostcost effectiveinnovationinterestpreventprogramssizetransmission process
项目摘要
DESCRIPTION (provided by applicant): Pooling of specimens to increase efficiency of screening individuals for rare diseases has a long history, dating back to screening of syphilis in military inductees in the 1940s. Over the years, specimen pooling or group testing has been applied in entomology, genetics, international trade, the pharmaceutical and blood bank industries, computer science, analytical chemistry, and many other areas. In the context of infectious diseases, group testing is typically used for (i) case identification, i.e., detecting all individuals having the disease of interest, and (ii) prevalence estimation, i.e., estimating the proportion of individuals in the population having a particular disease. As an example of the former, currently the nation's blood banks and the state of North Carolina's public HIV testing system employ specimen pooling to detect individuals recently infected with HIV. Group testing can be more efficient, accurate, and precise than individual testing; yet, many of the results supporting the use of group testing have gone unrecognized in the infectious disease setting owing to the vast and diverse group testing literature. We propose to research statistical aspects of group testing with application to case identification and prevalence estimation in HIV/AIDS and other infectious diseases. Our specific aims are to derive and compare the operating characteristics of multistage and array based group testing algorithms for both the identification and estimation problems in the presence of test error. Models for test error will consider constant and pool size dependent sensitivity and specificity. We hypothesize that array testing algorithms are superior to conventional multistage testing algorithms in terms of efficiency and accuracy. While the methodology is motivated by detection of acute HIV, our results will be directly applicable to other infectious diseases.
描述(由申请人提供):汇集样本以提高罕见疾病筛查个体的效率有着悠久的历史,可以追溯到20世纪40年代对入伍军人进行梅毒筛查。多年来,标本汇集或群体测试已应用于昆虫学、遗传学、国际贸易、制药和血库行业、计算机科学、分析化学和许多其他领域。在传染病方面,群体检测通常用于(i)病例识别,即检测所有患有感兴趣的疾病的个体,以及(ii)流行率估计,即估计患有特定疾病的个体在人口中的比例。作为前者的一个例子,目前全国的血库和北卡罗来纳州的公共艾滋病毒检测系统采用标本池来检测最近感染艾滋病毒的个体。群体测试可以比个人测试更有效、准确和精确;然而,由于大量和多样化的群体测试文献,许多支持使用群体测试的结果在传染病环境中未得到承认。我们建议研究群体测试的统计方面,并将其应用于艾滋病毒/艾滋病和其他传染病的病例识别和流行率估计。我们的具体目标是推导和比较多级和基于阵列的组测试算法在存在测试误差的识别和估计问题上的工作特性。测试误差模型将考虑常数和池大小相关的灵敏度和特异性。我们假设阵列测试算法在效率和精度方面优于传统的多阶段测试算法。虽然该方法的动机是检测急性艾滋病毒,但我们的结果将直接适用于其他传染病。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Three-dimensional array-based group testing algorithms.
- DOI:10.1111/j.1541-0420.2008.01158.x
- 发表时间:2009-09
- 期刊:
- 影响因子:1.9
- 作者:Kim HY;Hudgens MG
- 通讯作者:Hudgens MG
Optimal Configuration of a Square Array Group Testing Algorithm.
- DOI:10.1080/03610920903391303
- 发表时间:2011-01-01
- 期刊:
- 影响因子:0
- 作者:Hudgens MG;Kim HY
- 通讯作者:Kim HY
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael G Hudgens其他文献
Finite sample performance of optimal treatment rule estimators with right-censored outcomes
具有右删失结果的最佳治疗规则估计器的有限样本性能
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Michael Jetsupphasuk;Michael G Hudgens;Jess K. Edwards;Stephen R. Cole - 通讯作者:
Stephen R. Cole
Barriers to Cervical Cancer Screening by Sexual Orientation Among Low-Income Women in North Carolina
北卡罗来纳州低收入女性因性取向而面临的宫颈癌筛查障碍
- DOI:
10.1007/s10508-024-02844-2 - 发表时间:
2024 - 期刊:
- 影响因子:3.8
- 作者:
Jennifer C. Spencer;Brittany M. Charlton;Peyton K Pretsch;Phillip W Schnarrs;Lisa P. Spees;Michael G Hudgens;L. Barclay;Stephanie B Wheeler;Noel T Brewer;Jennifer S. Smith - 通讯作者:
Jennifer S. Smith
Group Testing for Sars-Cov-2 to Enable Rapid Scale-Up of Testing and Real-Time Surveillance of Incidence
对 Sars-Cov-2 进行分组测试,以实现快速扩大测试规模和实时监测发病率
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Christopher D. Pilcher;Daniel Westreich;Michael G Hudgens - 通讯作者:
Michael G Hudgens
Semiparametric g-computation for survival outcomes with time-fixed exposures: an illustration.
固定时间暴露下生存结果的半参数 g 计算:示例。
- DOI:
10.1016/j.annepidem.2024.05.013 - 发表时间:
2024 - 期刊:
- 影响因子:5.6
- 作者:
Jess K. Edwards;Stephen R. Cole;P. Zivich;Michael G Hudgens;Tiffany L. Breger;B. Shook‐Sa - 通讯作者:
B. Shook‐Sa
Michael G Hudgens的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael G Hudgens', 18)}}的其他基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Coordinating Center- Supplement
HIV/AIDS 干预青少年医学试验网络 (ATN) 协调中心 - 补充资料
- 批准号:
10444497 - 财政年份:2021
- 资助金额:
$ 7.02万 - 项目类别:
Causal Inference in Infectious Disease Prevention Studies
传染病预防研究中的因果推断
- 批准号:
10410408 - 财政年份:2009
- 资助金额:
$ 7.02万 - 项目类别:
Causal inference in infectious disease prevention studies
传染病预防研究中的因果推断
- 批准号:
8197245 - 财政年份:2009
- 资助金额:
$ 7.02万 - 项目类别:
Causal inference in infectious disease prevention studies
传染病预防研究中的因果推断
- 批准号:
8385550 - 财政年份:2009
- 资助金额:
$ 7.02万 - 项目类别:
Causal Inference in Infectious Disease Prevention Studies
传染病预防研究中的因果推断
- 批准号:
10199964 - 财政年份:2009
- 资助金额:
$ 7.02万 - 项目类别:
Causal Inference in Infectious Disease Prevention Studies
传染病预防研究中的因果推断
- 批准号:
9195685 - 财政年份:2009
- 资助金额:
$ 7.02万 - 项目类别:
Causal inference in infectious disease prevention studies
传染病预防研究中的因果推断
- 批准号:
7993542 - 财政年份:2009
- 资助金额:
$ 7.02万 - 项目类别:
Causal inference in infectious disease prevention studies
传染病预防研究中的因果推断
- 批准号:
7768360 - 财政年份:2009
- 资助金额:
$ 7.02万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 7.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Operating Grants